Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer

Human Gene Therapy

Volumn 21, Issue 7, 2010, Pages 865-875

  Multhaup, Megan ^a   Karlen, Andrea D ^a   Swanson, Debra L ^a   Wilber, Andrew ^b   Somia, Nikunj V ^a   Cowan, Morton J ^c   McIvor, R Scott ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDONUCLEASE; LENTIVIRUS VECTOR; PHOSPHOGLYCERATE KINASE; PROTEIN ARTEMIS; UNCLASSIFIED DRUG; DCLRE1C PROTEIN, HUMAN; NUCLEAR PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; EMBRYO; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC RECOMBINATION; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; SEVERE COMBINED IMMUNODEFICIENCY; ANIMAL; CELL CULTURE; CELL SURVIVAL; GENE VECTOR; GENETICS; HUMAN; LENTIVIRINAE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LENTIVIRUS; MICE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS;

EID: 77954906403     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.162     Document Type: Article

References (40)

1. Agarwal, S., Nikolai, B., Yamaguchi, T., Lech, P., and Somia, N.V. (2006). Construction and use of retroviral vectors encoding the toxic gene barnase. Mol. Ther. 14, 555-563.
2. Aiuti, A., Cattaneo, F., Galimberti, S., Benninghoff, U., Cassani, B., Callegaro, L., Scaramuzza, S., Andolfi, G., Mirolo, M., Brigida, I., Tabucchi, A., Carlucci, F., Eibl, M., Aker, M., Slavin, S., al-Mousa, H., al Ghonaium, A., Ferster, A., Duppenthaler, A., Notarangelo, L., Wintergerst, U., Buckley, R.H., Bregni, M., Marktel, S., Valsecchi, M.G., Rossi, P., Ciceri, F., Miniero, R., Bordignon, C., and Roncarolo, M.G. (2009). Gene therapy for immunodeficiency due to adenosine deam-inase deficiency. N. Engl. J. Med. 360, 447-458.
3. Amorosi, S., Russo, I., Amodio, G., Garbi, C., Vitiello, L., Palamaro, L., Adriani, M., Vigliano, I., and Pignata, C. (2009). The cellular amount of the common g-chain influences spontaneous or induced cell proliferation. J. Immunol. 182, 3304-3309.
4. Benjelloun, F., Garrigue, A., Demerens-de Chappedelaine, C., Soulas-Sprauel, P., Malassis-Seris, M., Stockholm, D., Hauer, J., Blondeau, J., Riviere, J., Lim, A., le Lorc'h, M., Romana, S., Brousse, N., Paques, F., Galy, A., Charneau, P., Fischer, A., de Villartay, J.P., and Cavazzana-Calvo, M. (2008). Stable and functional lymphoid reconstitution in Artemis-deficient mice following lentiviral Artemis gene transfer into hematopoietic stem cells. Mol. Ther. 16, 1490-1499.
5. Cavazzana-Calvo, M., Hacein-Bey, S., De Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.L., Bousso, P., Deist, F.L., and Fischer, A. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672.
6. Clark, K.J., Carlson, D.F., Foster, L.K., Kong, B.W., Foster, D.N., and Fahrenkrug, S.C. (2007). Enzymatic engineering of the porcine genome with transposons and recombinases. BMC Biotechnol. 7, 42.
7. Gaspar, H.B., Parsley, K.L., Howe, S., King, D., Gilmour, K.C., Sinclair, J., Brouns, G., Schmidt, M., von Kalle, C., Barington, T., Jakobsen, M.A., Christensen, H.O., al Ghonaium, A., White, H.N., Smith, J.L., Levinsky, R.J., Ali, R.R., Kinnon, C., and Thrasher, A.J. (2004). Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gam-maretroviral vector. Lancet 364, 2181-2187.
8. Gori, J.L., Podetz-Pedersen, K., Swanson, D., Karlen, A.D., Gunther, R., Somia, N.V., and McIvor, R.S. (2007). Protection of mice from methotrexate toxicity by ex vivo transduction using lentivirus vectors expressing drug-resistant dihy-drofolate reductase. J. Pharmacol. Exp. Ther. 322, 989-997.
9. Grawunder, U., Wilm, M., Wu, X., Kulesza, P., Wilson, T.E., Mann, M., and Lieber, M.R. (1997). Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature 388, 492-495.
10. Grawunder, U., Zimmer, D., Kulesza, P., and Lieber, M.R. (1998). Requirement for an interaction of XRCC4 with DNA ligase IV for wild-type V(D)J recombination and DNA double-strand break repair in vivo. J. Biol. Chem. 273, 24708-24714.
11. Hacein-Bey-Abina, S., Fischer, A., and Cavazzana-Calvo, M. (2002). Gene therapy of X-linked severe combined immunodeficiency. Int. J. Hematol. 76, 295-298.
12. Hacein-Bey-Abina, S., Garrigue, A., Wang, G.P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., Asnafi, V., MacIntyre, E., Dal Cortivo, L., Radford, I., Brousse, N., Sigaux, F., Moshous, D., Hauer, J., Borkhardt, A., Belohradsky, B.H., Wintergerst, U., Velez, M.C., Leiva, L., Sorensen, R., Wulffraat, N., Blanche, S., Bushman, F.D., Fischer, A., and Cavazzana-Calvo, M. (2008). Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118, 3132-3142.
13. Howe, S.J., Mansour, M.R., Schwarzwaelder, K., Bartholomae, C., Hubank, M., Kempski, H., Brugman, M.H., Pike-Overzet, K., Chatters, S.J., de Ridder, D., Gilmour, K.C., Adams, S., Thornhill, S.I., Parsley, K.L., Staal, F.J., Gale, R.E., Linch, D.C., Bayford, J., Brown, L., Quaye, M., Kinnon, C., Ancliff, P., Webb, D.K., Schmidt, M., von Kalle, C., Gaspar, H.B., and Thrasher, A.J. (2008). Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Invest. 118, 3143-3150.
14. 1 arrest after DNA damage. Environ. Health Perspect. 101(Suppl. 5), 55-58.
15. Kuerbitz, S.J., Plunkett, B.S., Walsh, W.V., and Kastan, M.B. (1992). Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. U.S.A. 89, 7491-7495.
16. Li, L., Moshous, D., Zhou, Y., Wang, J., Xie, G., Salido, E., Hu, D., de Villartay, J.P., and Cowan, M.J. (2002). A founder mutation in Artemis, an SNM1-like protein, causes SCID in Athabascan-speaking Native Americans. J. Immunol. 168, 6323-6329.
17. Li, L., Salido, E., Zhou, Y., Bhattacharyya, S., Yannone, S.M., Dunn, E., Meneses, J., Feeney, A.J., and Cowan, M.J. (2005). Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation. J. Immunol. 174, 2420-2428.
18. Ma, Y., Pannicke, U., Schwarz, K., and Lieber, M.R. (2002). Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108, 781-794.
19. McBlane, J.F., van Gent, D.C., Ramsden, D.A., Romeo, C., Cuomo, C.A., Gellert, M., and Oettinger, M.A. (1995). Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 83, 387-395.
20. Mikkelsen, J.G., Yant, S.R., Meuse, L., Huang, Z., Xu, H., and Kay, M.A. (2003). Helper-independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo. Mol. Ther. 8, 654-665.
21. Moshous, D., Li, L., Chasseval, R., Philippe, N., Jabado, N., Cowan, M.J., Fischer, A., and de Villartay, J.P. (2000). A new gene involved in DNA double-strand break repair and V(D)J recombination is located on human chromosome 10p. Hum. Mol. Genet. 9, 583-588.
22. Moshous, D., Callebaut, I., de Chasseval, R., Corneo, B., Cavazzana-Calvo, M., le Deist, F., Tezcan, I., Sanal, O., Bertrand, Y., Philippe, N., Fischer, A., and de Villartay, J.P. (2001). Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105, 177-186.
23. Mostoslavsky, G., Fabian, A.J., Rooney, S., Alt, F.W., and Mulligan, R.C. (2006). Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proc. Natl. Acad. Sci. U.S.A. 103, 16406-16411.
24. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F., and Riccardi, C. (1991). A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139, 271-279.
25. Oettinger, M.A., Schatz, D.G., Gorka, C, and Baltimore, D. (1990). RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248, 1517-1523.
26. Olive, P.L., and Banath, J.P. (2006). The comet assay: A method to measure DNA damage in individual cells. Nat. Protocols 1, 23-29.
27. O'Marcaigh, A.S., Desantes, K., Hu, D., Pabst, H., Horn, B., Li, L., and Cowan, M.J. (2001). Bone marrow transplantation for T~B~ severe combined immunodeficiency disease in Athabascan-speaking native Americans. Bone Marrow Transplant. 27, 703-709.
28. Ramezani, A., Hawley, T.S., and Hawley, R.G. (2000). Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol. Ther. 2, 458-469.
29. Roth, D.B., Menetski, J.P., Nakajima, P.B., Bosma, M.J., and Gellert, M. (1992). V(D)J recombination: Broken DNA molecules with covalently sealed (hairpin) coding ends in SCID mouse thymocytes. Cell 70, 983-991.
30. Rubinson, D.A., Dillon, C.P., Kwiatkowski, A.V., Sievers, C, Yang, L., Kopinja, J., Rooney, D.L., Zhang, M., Ihrig, M.M., McManus, M.T., Gertler, F.B., Scott, M.L., and van Parijs, L. (2003). A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33, 401-406.
31. 6-methylguanine-DNA methyltransferase in hematopoietic cells. DNA Repair 6, 1187-1196.
32. Schreiber, E., Matthias, P., Muller, M.M., and Schaffner, W. (1989). Rapid detection of octamer binding proteins with "mini-extracts,'' prepared from a small number of cells. Nucleic Acids Res. 17, 6419.
33. van Gent, D.C., McBlane, J.F., Ramsden, D.A., Sadofsky, M.J., Hesse, J.E., and Gellert, M. (1996). Initiation of V(D)J recombinations in a cell-free system by RAG1 and RAG2 proteins. Curr. Top. Microbiol. Immunol. 217, 1-10.
34. West, R.B., Yaneva, M., and Lieber, M.R. (1998). Productive and nonproductive complexes of Ku and DNA-dependent protein kinase at DNA termini. Mol. Cell. Biol. 18, 5908-5920.
35. Wilber, A., Frandsen, J.L., Wangensteen, K.J., Ekker, S.C., Wang, X., and McIvor, R.S. (2005). Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging. Hum. Gene Ther. 16, 1325-1332.
36. Wilber, A., Linehan, J.L., Tian, X., Woll, P.S., Morris, J.K., Belur, L.R., McIvor, R.S., and Kaufman, D.S. (2007). Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem Cells 25, 2919-2927.
37. Yaneva, M., Kowalewski, T., and Lieber, M.R. (1997). Interaction of DNA-dependent protein kinase with DNA and with Ku: Biochemical and atomic-force microscopy studies. EMBO J. 16, 5098-5112.
38. 2/M DNA damage checkpoint response. Mol. Cell. Biol. 24, 9207-9220.
39. Zhu, C., Bogue, M.A., Lim, D.S., Hasty, P., and Roth, D.B. (1996). Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 86, 379-389.
40. Zufferey, R., Nagy, D., Mandel, R.J., Naldini, L., and Trono, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15, 871-875.